DAM
EW icon

Draper Asset Management’s Edwards Lifesciences EW Stock Holding History

Draper Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,919
Closed -$406K – 57
2021
Q2 		$406K Sell
3,919
-18
-0.5% -$1.7K 0.4% 25
2021
Q1 		$329K Buy
+3,937
New +$333K 0.35% 28

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Draper Asset Management's EW Position: Q3 2021 in Review

Draper Asset Management sold out of Edwards Lifesciences (EW) in Q3 2021, closing a stake of 3,919 shares — an estimated $406K sold.

Draper Asset Management first reported a position in EW in Q1 2021 and held it in 2 quarters. The position peaked at $406K in Q2 2021. 1,229 funds tracked by Wall St. Rank hold EW as of Q3 2021.

  • Draper Asset Management reported no remaining Edwards Lifesciences position as of Q3 2021 after selling out during the quarter.
  • Draper Asset Management sold 3,919 Edwards Lifesciences shares in Q3 2021, an estimated $406K.
  • Draper Asset Management first reported a position in Edwards Lifesciences in Q1 2021 and held it in 2 quarters.
  • Draper Asset Management's Edwards Lifesciences position peaked at $406K in Q2 2021.
  • 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Draper Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.